PRPH – ProPhase Labs Inc

ProPhase Labs, Inc.

PRPH

$0.3261

Name : ProPhase Labs, Inc.

Sector : Healthcare

Industry: Diagnostics & Research

Mark. Cap: $13,546,585.00

EPSttm : -2.23

ProPhase Labs, Inc.

$0.3261

9.34%

$0.0336

Float Short %

0.39

Margin Of Safety %

Put/Call OI Ratio

0.01

EPS Next Q Diff

0.01

EPS Last/This Y

2.05

EPS This/Next Y

0.56

Price

0.33

Target Price

Analyst Recom

Performance Q

1.02

Relative Volume

0.34

Beta

-0.49

Ticker: PRPH

21 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-07-04	PRPH	0.4185	0.01	0.00	5402
2025-07-07	PRPH	0.4463	0.01	0.00	5436
2025-07-08	PRPH	0.434	0.01	0.07	5436
2025-07-09	PRPH	0.4242	0.01	0.00	5492
2025-07-10	PRPH	0.4275	0.01	0.00	5518
2025-07-11	PRPH	0.4268	0.01	0.00	5513
2025-07-14	PRPH	0.425	0.01	0.00	5513
2025-07-15	PRPH	0.4161	0.01	0.00	5563
2025-07-16	PRPH	0.3806	0.01	2.00	5567
2025-07-17	PRPH	0.38	0.01	0.02	5567
2025-07-18	PRPH	0.3656	0.01	0.00	5583
2025-07-21	PRPH	0.4021	0.02	0.00	3014
2025-07-22	PRPH	0.3904	0.01	0.00	4623
2025-07-23	PRPH	0.4222	0.01	0.00	5338
2025-07-24	PRPH	0.42	0.01	0.71	5783
2025-07-25	PRPH	0.4599	0.01	0.00	5795
2025-07-28	PRPH	0.45	0.01	0.02	7578
2025-07-29	PRPH	0.3513	0.01	0.04	7753
2025-07-30	PRPH	0.3513	0.01	0.00	7851
2025-07-31	PRPH	0.3578	0.01	0.08	8059
2025-08-01	PRPH	0.3261	0.01	0.00	8180
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

21 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-07-04	PRPH	0.42	54.6	-	-0.56
2025-07-07	PRPH	0.44	54.6	-	-0.56
2025-07-08	PRPH	0.43	54.6	-	-0.56
2025-07-09	PRPH	0.42	54.6	-	-0.56
2025-07-10	PRPH	0.43	54.6	-	-0.56
2025-07-11	PRPH	0.42	54.6	-	-0.56
2025-07-14	PRPH	0.43	54.6	-	-0.56
2025-07-15	PRPH	0.42	54.6	-	-0.56
2025-07-16	PRPH	0.38	54.6	-	-0.56
2025-07-17	PRPH	0.37	54.6	-	-0.56
2025-07-18	PRPH	0.36	54.6	-	-0.56
2025-07-21	PRPH	0.41	54.6	-	-0.56
2025-07-22	PRPH	0.39	54.6	-	-0.56
2025-07-23	PRPH	0.44	54.6	-	-0.56
2025-07-24	PRPH	0.42	54.6	-	-0.56
2025-07-25	PRPH	0.47	54.6	-	-0.56
2025-07-28	PRPH	0.45	54.6	-	-0.56
2025-07-29	PRPH	0.35	54.6	-	-0.56
2025-07-30	PRPH	0.36	54.6	-	-0.56
2025-07-31	PRPH	0.36	54.6	-	-0.56
2025-08-01	PRPH	0.33	54.6	-	-0.56
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-07-04	PRPH	0.00	103.17	0.43
2025-07-07	PRPH	0.00	102.86	0.43
2025-07-08	PRPH	0.00	102.86	0.43
2025-07-09	PRPH	0.00	102.86	0.43
2025-07-10	PRPH	0.00	102.86	0.43
2025-07-11	PRPH	0.00	102.86	3.00
2025-07-14	PRPH	0.00	104.76	3.00
2025-07-15	PRPH	0.00	104.76	3.00
2025-07-16	PRPH	0.00	104.76	3.00
2025-07-17	PRPH	0.00	104.76	3.00
2025-07-18	PRPH	0.00	104.76	3.00
2025-07-21	PRPH	0.00	92.20	3.00
2025-07-22	PRPH	0.00	92.20	3.00
2025-07-23	PRPH	0.00	92.20	3.00
2025-07-24	PRPH	0.00	92.20	3.00
2025-07-25	PRPH	0.00	92.20	0.39
2025-07-28	PRPH	0.00	91.23	0.39
2025-07-29	PRPH	0.00	91.23	0.39
2025-07-30	PRPH	0.00	91.23	0.39
2025-07-31	PRPH	0.00	91.23	0.39
2025-08-01	PRPH	0.00	91.23	0.39
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

-0.12

Avg. EPS Est. Current Quarter

-0.15

Avg. EPS Est. Next Quarter

-0.11

Insider Transactions

Institutional Transactions

91.23

Beta

-0.49

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

-98.4

Target Price

P/E

Forward P/E

PEG

P/S

1.06

P/B

0.87

P/Free Cash Flow

EPS

-1.5

Average EPS Est. Cur. Y

-0.56

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-217.64

Relative Volume

0.34

Return on Equity vs Sector %

-309

Return on Equity vs Industry %

-295.8

EPS 1 7Days Diff

EPS 1 30Days Diff

0.24

EBIT Estimation

ProPhase Labs, Inc.

Sector: Healthcare

Industry: Diagnostics & Research

Employees: 96

ProPhase Labs, Inc. develops and commercializes novel drugs, dietary supplements, and compounds in the United States. It operates through two segments: Diagnostic Services and Consumer Products. The company provides a range of dietary supplements under the TK supplements, including Legendz XL, a male sexual enhancement; and Triple Edge XL, an energy and stamina booster. It also develops BE-Smart Esophageal Pre-Cancer diagnostics screening test for early detection of esophageal cancer; genomics testing technologies to analyze entire genomes, including the genes and chromosomes in deoxyribonucleic acid; DNA Expand, a platform that allows consumers to upload their DNA data from previous DNA tests obtained from other service providers; and LB-1 and LB-2 for the treatment of cancer, inflammatory diseases or symptoms and memory related syndromes, diseases or symptoms, including dementia and Alzheimer's disease. In addition, the company provides a broad range of COVID-19 related clinical diagnostic and testing services, comprising PCR testing for COVID-19, and Influenza A and B, as well as rapid antigen testing for COVID-19. It offers its genome sequencing products to consumers online with plans to sell in food, drug, and mass retail stores. The company was formerly known as The Quigley Corporation. ProPhase Labs, Inc. was founded in 1989 and is headquartered in Garden City, New York.

stock quote shares PRPH – ProPhase Labs Inc Stock Price stock today

news today PRPH – ProPhase Labs Inc stock forecast ,stock prediction 2023 2024 2025

marketwatch PRPH – ProPhase Labs Inc yahoo finance google finance

stock history PRPH – ProPhase Labs Inc invest stock market

stock prices PRPH premarket after hours

ticker PRPH fair value insiders trading

Investment involves risk. As a general rule, you should only trade in financial products that you are familiar with and understand the risk associated with them. The risk warning described in each financial product below is not exhaustive, you should carefully consider your investment experience, financial situation, investment objective, risk tolerance level and consult your independent financial adviser as to the suitability of your situation prior making any investment.

PRPH – ProPhase Labs Inc

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: PRPH

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Get Started

About

Last Quarter Act. EPS

Average EPS Est. Cur. Y